Pain to Relief in 60 Seconds1

Intended for UK Healthcare Professionals

Effective Analgesia

The STOP! trial was a randomised multicentre placebo-controlled study of 300 trauma patients in the emergency department conducted at six sites in the UK.2*

Methoxyflurane reduced pain severity significantly more than placebo (p<0.0001) at all time points tested.2

84.6% of patients in the methoxyflurane group experienced their first pain relief within 10 inhalations.2


*A total of 149 patients received inhaled methoxyflurane and 149 patients received placebo.2 The primary endpoint was the change in pain intensity measured using the VAS from baseline to 5, 10, 15 and 20 minutes after the start of study drug inhalation.2

This section of the website is intended for healthcare professionals only.

Please confirm you are a healthcare professional to continue.

You are about to leave to go to an external website.

Galen Ltd does not take any responsibility for content hosted on external websites.